戻る
Shanghai Bio-heart Biological Technology Co., Ltd. (02185.HK)価格
02185.HK 株価推移チャート
BIOHEART-B (02185.HK)
Shanghai Bio-heart Biological Technology Co., Ltd.
HK$6.29
4.83%
$0.29
休場: Jan 16, 16:00:00 HKT
データなしEarnings FAQ
02185.HKの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Shanghai Bio-heart Biological Technology Co., Ltd. 02185.HKの前四半期の収益はどうでしたか？
Shanghai Bio-heart Biological Technology Co., Ltd.の収益見積もりはいくらですか？
Shanghai Bio-heart Biological Technology Co., Ltd.の収益品質スコアはどれくらいですか？
Shanghai Bio-heart Biological Technology Co., Ltd.はいつ収益を報告しますか？
Shanghai Bio-heart Biological Technology Co., Ltd.の予想収益はいくらですか？
Shanghai Bio-heart Biological Technology Co., Ltd.は収益予想を上回りましたか？
主要データ
前終値
$5.89
始値
$6
当日レンジ
$6 - $6.31
52週レンジ
$1.43 - $10.77
取引高
481.2K
平均取引高
1.0M
1株当たり利益(TTM)
-0.40
配当利回り
--
時価総額
$1.4B
BIOHEART-Bとは何ですか？
Shanghai Bio-Heart Biological Technology Co., Ltd. engages in the research and development of interventional cardiovascular device therapies. The company is headquartered in Shanghai, Shanghai and currently employs 70 full-time employees. The company went IPO on 2021-12-23. The firm's main businesses are the development and production of interventional cardiovascular devices. The firm's main products comprise fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The firm's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension. The firm's products are used in addressing the unmet medical needs of Chinese patients for the treatment of coronary artery diseases and the unmet medical needs of patients for the treatment of uncontrolled hypertension. The firm mainly conducts its businesses in the domestic market and overseas markets.